Skip to search boxSkip to navigationSkip to main content

Osteoporotic fractures in patients with systemic lupus erythematosus and end stage renal disease

  • Brian Le(corresponding author)
    ,
  • J. L. Waller
    ,
  • R. Radhakrishnan
    ,
  • S. J. Oh
    ,
  • M. F. Kheda
    ,
  • N. S. Nahman
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Background: The incidence of end stage renal disease (ESRD) in patients with systemic lupus erythematosus (SLE) is rising. However, the relationship between osteoporotic fractures and SLE in the setting of ESRD remains uninvestigated. The purpose of this study was to compare the frequency of incident osteoporotic fractures in patients with ESRD with and without SLE, to identify risk factors for fractures in patients with SLE and ESRD, and to examine the contribution of these fractures to mortality. Methods: Retrospective cohort study of patients with SLE (n = 716) and a 5% random sample of controls without SLE (n = 4176) in the United States Renal Data System (USRDS) from years 2006–2008 enrolled in Medicare Part D. Results: Fractures occurred in 10.6% (n = 76) of patients with SLE and ESRD and 12.1% (n = 507) of patients with ESRD without SLE (p = 0.24). Older age (adjusted relative risk 1.02, 95% confidence interval 1.01–1.04) was associated with an increased risk for fracture in patients with SLE and ESRD. In multivariable analyses, vertebral and hip fractures more than doubled the risk for mortality. Conclusions: The frequency of osteoporotic fractures in patients with SLE and ESRD is similar to the general population of patients with ESRD. Vertebral and hip fractures are significant contributors to mortality in patients with SLE and ESRD. Fracture prevention, in particular, for elderly patients with SLE and ESRD, should be considered. Summary: SLE is not an independent risk factor for fractures in patients with ESRD. However, among patients with SLE and ESRD, vertebral and hip fractures are significant contributors to mortality.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 17-24 (8 pages)

Journal (Volume, Issue Number)

Lupus (Volume 27, Issue 1)

Publication milestones

  • Published - 01/01/2018

Publication status

Published - 01/01/2018

ISSN

0961-2033

Publication IDs

  • Scopus: 85038438272
  • PubMed: 28530467
  • ORCID: /0000-0003-4066-4541/work/68027431

Publication metrics

Metrics

SciVal
FWCI
0.54
SciVal
Author count
7
SciVal
citations
4
SciVal
Paper percentile
62
Scopus
citations
Fractional count
3
Fractional count
0.43
Fractional count
4
Fractional count
0.57
Fractional count
3
Fractional count
1

PlumX, opens in new tab

Captures
24
Citation count
6

Funding Details

The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was made possible by generous funding from the Rheumatology Research Foundation’s Ephraim P. Engleman Endowed Resident Research Preceptorship Award. This work was supported by reserve funds research grant the Translational Research Program of the Department of Medicine, Augusta University. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. government.
FundersFunding numbers
Division Chief Hospital Medicine Department of Medicine Medical College of Georgia at Augusta University Augusta GA USA.
-
RRF
-